Bank of America’s Tevogen Inc. Common Stock TVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-497
Closed -$8.23K 6978
2025
Q4
$8.23K Buy
497
+221
+80% +$5.75K ﹤0.01% 6194
2025
Q3
$10.8K Buy
276
+23
+9% +$1.13K ﹤0.01% 7189
2025
Q2
$15.8K Buy
253
+46
+22% +$2.62K ﹤0.01% 7103
2025
Q1
$11.2K Sell
207
-159
-43% -$10.5K ﹤0.01% 7094
2024
Q4
$18.9K Buy
366
+23
+7% +$1.5K ﹤0.01% 6859
2024
Q3
$6.32K Buy
343
+123
+56% +$3.6K ﹤0.01% 6969
2024
Q2
$7.96K Buy
+220
New +$14.3K ﹤0.01% 6928

Other funds holding TVGN

Bank of America's TVGN Position: Q1 2026 in Review

Bank of America sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2026, closing a stake of 497 shares — an estimated $8.23K sold.

Bank of America first reported a position in TVGN in Q2 2024 and held it in 7 quarters. The position peaked at $18.9K in Q4 2024. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Bank of America reported no remaining Tevogen Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 497 Tevogen Inc. Common Stock shares in Q1 2026, an estimated $8.23K.
  • Bank of America first reported a position in Tevogen Inc. Common Stock in Q2 2024 and held it in 7 quarters.
  • Bank of America's Tevogen Inc. Common Stock position peaked at $18.9K in Q4 2024.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.